The development and evaluation of a subcutaneous infusion delivery system based on osmotic pump control and gas drive

References

• Agarwal P, Rupenthal ID. (2013). Injectable implants for the sustained release of protein and peptide drugs. Drug Discov Today 18:337–49
   PubMed Web of Science ®Google Scholar
• Befon S, Mystakidou K, Lyra M, et al. (2000). Continuous subcutaneous octreotide in gastrointestinal cancer patients: pain control and beta-endorphin levels. Anticancer Res 20:4039–46
   PubMed Web of Science ®Google Scholar
• Champoux N, Dusouich P, Ravaoarinorom M, et al. (1996). Single-dose pharmacokinetics of ampicillin and tobramycin administered by hypodermoclysis in young and older healthy volunteers. Br J Clin Pharmacol 42:325–31
   PubMed Web of Science ®Google Scholar
• Chen Z, Liu D, Wang J, et al. (2014). Development of nanoparticles-in-microparticles system for improved local retention after intra-articular injection. Drug Deliv 21:342–50
   PubMed Web of Science ®Google Scholar
• Colombo P, Bettini R, Santi P, et al. (1996). Analysis of the swelling and release mechanisms from drug delivery systems with emphasis on drug solubility and water transport. J Control Release 39:231–7
   Web of Science ®Google Scholar
• De Conno F, Caraceni A, Zecca E, et al. (1991). Continuous subcutaneous infusion of hyoscine butylbromide reduces secretion sin patients with gastrointestinal obstruction. J Pain Symptom Manage 6:484–6
   PubMed Web of Science ®Google Scholar
• Ehwald M, Adleff H, Geggier P, et al. (2006). A long-term stable and adjustable osmotic pump for small volume flow based on principles of phloem loading. Biotechnol Bioeng 94:37–42
   PubMed Web of Science ®Google Scholar
• Fujikawa T, Imbe H, Date M, et al. (2012). Severe insulin allergy successfully treated with continuous subcutaneous insulin infusion. Diabetes Res Clin Pract 97:e31–3
   PubMed Web of Science ®Google Scholar
• Gong W, Ma R, Mei D, et al. (2014). A novel subcutaneous infusion delivery system based on osmotic pump: in vitro and in vivo evaluation. Drug Deliv 21:1–7
   PubMed Web of Science ®Google Scholar
• Guo JH. (1993). Effects of plasticizers on water permeation and mechanical properties of cellulose-acetate-antiplasticization in slightly plasticized polymer film. Dr Dev Ind Pharm 19:1541–55
   Web of Science ®Google Scholar
• Herrlich S, Spieth S, Messner S, et al. (2012). Osmotic micropumps for drug delivery. Adv Drug Deliv Rev 64:1617–27
   PubMed Web of Science ®Google Scholar
• Herndon CM, Fike DS. (2001). Continuous subcutaneous infusion practices of United States hospices. J Pain Symptom Manage 22:1027–34
   PubMed Web of Science ®Google Scholar
• Hirsch IB, Bode BW, Garg S, et al. (2005). Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII. Diabetes Care 28:533–8
   PubMed Web of Science ®Google Scholar
• Ilfeld BM, Morey TE, Enneking FK. (2003). Portable infusion pumps used for continuous regional analgesia: delivery rate accuracy and consistency. Reg Anesth Pain Med 28:424–32
   PubMed Web of Science ®Google Scholar
• Justad M. (2009). Continuous subcutaneous infusion: an efficacious, cost-effective analgesia alternative at the end of life. Home Healthcare Nurs 27:140–7
   PubMedGoogle Scholar
• Kirmse J. (2009). The nurse's role in administration of intravenous immunoglobulin therapy. Home Healthcare Nurs 27:104–11
   PubMedGoogle Scholar
• Kumaravelrajan R, Narayanan N, Suba V, et al. (2010). Simultaneous delivery of nifedipine and metoprolol tartarate using sandwiched osmotic pump tablet system. Int J Pharm 399:60–70
   PubMed Web of Science ®Google Scholar
• Leahy MG, Pitfield D, Popert S, et al. (1992). Phase I study comparing continuous infusion of recombinant interleukin-2 by subcutaneous or intravenous administration. Eur J Cancer 28:1049–51
   Web of Science ®Google Scholar
• Lee H, Cima MJ. (2011). An intravesical device for the sustained delivery of lidocaine to the bladder. J Control Release 149:133–9
   PubMed Web of Science ®Google Scholar
• Liu L, Ku J, Khang G, et al. (2000). Nifedipine controlled delivery by sandwiched osmotic tablet system. J Control Release 68:145–56
   PubMed Web of Science ®Google Scholar
• Makhija SN, Vavia PR. (2003). Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine I. Cellulose acetate as a semipermeable membrane. J Control Release 89:5–18
   PubMed Web of Science ®Google Scholar
• Malaterre V, Ogorka J, Loggia N, et al. (2009). Approach to design push-pull osmotic pumps. Int J Pharm 376:56–62
   PubMed Web of Science ®Google Scholar
• McClelland GA, Sutton SC, Engle K, et al. (1991). The solubility-modulated osmotic pump: in vitro/in vivo release of diltiazem hydrochloride. Pharm Res 8:88–92
   PubMed Web of Science ®Google Scholar
• Mikkelsen Lynch P, Butler J, Huerta D, et al. (2000). A pharmacokineticand tolerability evaluation of two continuous subcutaneous infusionsystems compared to an oral controlled-release morphine. J Pain Symptom Manage 19:348–56
   PubMed Web of Science ®Google Scholar
• Moulin DE, Kreeft JH, Murray-Parsons N, et al. (1991). Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer pain. Lancet 337:465–8
   PubMed Web of Science ®Google Scholar
• Ofori-Kwakye K, Fell JT. (2003). Biphasic drug release from film-coated tablets. Int J Pharm 250:431–40
   PubMed Web of Science ®Google Scholar
• Ozdemir N, Sahin J. (1997). Design of a controlled release osmotic pump system of ibuprofen. Int J Pharm 158:91–7
   Web of Science ®Google Scholar
• Pasero C. (2002). Subcutaneous opioid infusion. Am J Nurs 102:61–2
   Web of Science ®Google Scholar
• Patte C, Pleus S, Wiegel C, et al. (2013). Effect of infusion rate and indwelling time on tissue resistance pressure in small-volume subcutaneous infusion like in continuous subcutaneous insulin infusion. Diabetes Technol Ther 15:289–94
   PubMed Web of Science ®Google Scholar
• Rani M, Mishra B. (2004). Comparative in vitro and in vivo evaluation of matrix, osmotic matrix, and osmotic pump tablets for controlled delivery of diclofenac sodium. AAPS Pharm Sci Tech 5:153–9
   Web of Science ®Google Scholar
• Roberts JA, Paratz J, Paratz E, et al. (2007). Continuous infusion of β-lactam antibioticsin severe infections: a review of its role. Int J Antimicrobial 30:11–8
   PubMed Web of Science ®Google Scholar
• Schen R. (1997). Administration of fluid by subcutaneous infusion: revival of a forgotten method. Harefuah 132:716–17
   PubMedGoogle Scholar
• Schulze JDR, Peters EE, Vickers AW, et al. (2005). Excipient effects on gastrointestinal transit and drug absorption in beagle dogs. Int J Pharm 300:67–75
   PubMed Web of Science ®Google Scholar
• Shokri J, Ahmadi P, Rashidi P, et al. (2008). Swellable elementary osmotic pump (SEOP): an effective device for delivery of poorly water-soluble drugs. Eur J Pharm Biopharm 68:289–97
   PubMed Web of Science ®Google Scholar
• Theeuwes F, Yum SI. (1976). Principles of the design and operation of generic osmotic pumps for the delivery of semisolid or liquid drug formulations. Ann Biomed Eng 4:343–53
   PubMed Web of Science ®Google Scholar
• Verma RK, Krishna DM, Garg S. (2002). Formulation aspects in the development of osmotically controlled oral drug delivery systems. J Control Release 79:7–27
   PubMed Web of Science ®Google Scholar
• Wasserman RL, Melamed I, Stein MR, et al. (2012). Recombinant human hyaluronidase-facilitated subcutaneous infusion of human immune globulins for primary immunodeficiency. J Allergy Clin Immunol 130:951–7
   PubMed Web of Science ®Google Scholar
• Wright JC, Leonard ST, Stevenson CL, et al. (2001). An in vivo/in vitro comparison with a leuprolide osmotic implant for the treatment of prostate cancer. J Control Release 75:1–10
   PubMed Web of Science ®Google Scholar